West Pharmaceutical Services (WST) Inventory (2009 - 2026)

West Pharmaceutical Services' Inventory history runs 18 years deep, the most recent figure standing at $452.6 million for Q1 2026.

• In Q1 2026, Inventory rose 16.44% year-over-year to $452.6 million; the TTM figure through Mar 2026 stood at $452.6 million (up 16.44% YoY), while the FY2025 annual figure was $443.9 million, up 17.75% from the prior year.
• Inventory came in at $452.6 million for Q1 2026 at West Pharmaceutical Services, up from $443.9 million in the prior quarter.
• In the past five years, Inventory ranged from a high of $452.6 million in Q1 2026 to a low of $377.0 million in Q4 2024.
• A 5-year average of $423.0 million and a median of $421.1 million in 2025 frame the typical range for Inventory.
• Across the five-year window, Inventory soared 34.27% in 2022 and retreated 13.27% in 2024, its largest moves.
• West Pharmaceutical Services' Inventory stood at $414.8 million in 2022, then grew by 4.8% to $434.7 million in 2023, then retreated by 13.27% to $377.0 million in 2024, then gained by 17.75% to $443.9 million in 2025, then gained by 1.96% to $452.6 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $452.6 million, $443.9 million, and $438.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison